These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8517691)

  • 1. Carnitine status and safety after administration of S-1108, a new oral cephem, to patients.
    Shimizu K; Saito A; Shimada J; Ohmichi M; Hiraga Y; Inamatsu T; Shimada K; Tanimura M; Fujita Y; Nishikawa T
    Antimicrob Agents Chemother; 1993 May; 37(5):1043-9. PubMed ID: 8517691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism of S-1108, a new oral cephem antibiotic, and metabolic profiles of its metabolites in humans.
    Totsuka K; Shimizu K; Konishi M; Yamamoto S
    Antimicrob Agents Chemother; 1992 Apr; 36(4):757-61. PubMed ID: 1503437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of cefditoren pivoxil on carnitine metabolism in pediatric patients].
    Fujii R; Chiba S; Numazaki K; Mori T; Terashima I; Meguro H; Mori A; Toyonaga Y; Sunakawa K; Satoh Y
    Jpn J Antibiot; 1993 Oct; 46(10):926-37. PubMed ID: 8254895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase I clinical studies of S-1108: safety and pharmacokinetics in a multiple-administration study with special emphasis on the influence on carnitine body stores.
    Nakashima M; Uematsu T; Oguma T; Yoshida T; Mizojiri K; Matsuno S; Yamamoto S
    Antimicrob Agents Chemother; 1992 Apr; 36(4):762-8. PubMed ID: 1503438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disposition of S-1108, a new oral cephem antibiotic, and metabolic fate of pivalic acid liberated from [pivaloyl-14C]S-1108 in rats and dogs.
    Mizojiri K; Futaguchi S; Norikura R; Katsuyama Y; Nagasaki T; Yoshimori T; Nakanishi M
    Antimicrob Agents Chemother; 1995 Jul; 39(7):1445-53. PubMed ID: 7492083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypocarnitinemia Observed in an Infant Treated with Short-Term Administration of Antibiotic Containing Pivalic Acid.
    Nakazaki K; Ogawa E; Ishige M; Ishige N; Fuchigami T; Takahashi S
    Tohoku J Exp Med; 2018 Apr; 244(4):279-282. PubMed ID: 29628457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preferential elimination of pivalate with supplemental carnitine via formation of pivaloylcarnitine in man.
    Melegh B; Sumegi B; Sherry AD
    Xenobiotica; 1993 Nov; 23(11):1255-61. PubMed ID: 8310709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of pivaloylcarnitine in human plasma and urine by high-performance liquid chromatography with fluorescence detection.
    Konishi M; Hashimoto H
    J Pharm Sci; 1992 Oct; 81(10):1038-41. PubMed ID: 1432617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pivampicillin-promoted excretion of pivaloylcarnitine in humans.
    Melegh B; Kerner J; Bieber LL
    Biochem Pharmacol; 1987 Oct; 36(20):3405-9. PubMed ID: 3675603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Influence of multiple-dose administration of cefetamet pivoxil on blood and urinary concentrations of carnitine and effects of simultaneous administration of carnitine with cefetamet pivoxil].
    Nakashima M; Kosuge K; Ishii I; Ohtsubo M
    Jpn J Antibiot; 1996 Oct; 49(10):966-79. PubMed ID: 8986559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact on carnitine homeostasis of short-term treatment with the pivalate prodrug cefditoren pivoxil.
    Brass EP; Mayer MD; Mulford DJ; Stickler TK; Hoppel CL
    Clin Pharmacol Ther; 2003 Apr; 73(4):338-47. PubMed ID: 12709724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction between pivaloylcarnitine and L-carnitine transport into L6 cells overexpressing hOCTN2.
    Todesco L; Bodmer M; Vonwil K; Häussinger D; Krähenbühl S
    Chem Biol Interact; 2009 Aug; 180(3):472-7. PubMed ID: 19539806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased acylcarnitine clearance and excretion in septic rats.
    Davis AT; Crady SK; Strong SA; Albrecht RM; Scholten DJ
    Biomed Biochim Acta; 1991; 50(1):81-6. PubMed ID: 1859390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of pivaloylcarnitine in pediatric patients with hypocarnitinemia after long-term administration of pivalate-containing antibiotics.
    Nakajima Y; Ito T; Maeda Y; Ichiki S; Sugiyama N; Mizuno M; Makino Y; Sugiura T; Kurono Y; Togari H
    Tohoku J Exp Med; 2010 Aug; 221(4):309-13. PubMed ID: 20651467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Children's toxicology from bench to bed--Liver injury (1): Drug-induced metabolic disturbance--toxicity of 5-FU for pyrimidine metabolic disorders and pivalic acid for carnitine metabolism.
    Ito T
    J Toxicol Sci; 2009; 34 Suppl 2():SP217-22. PubMed ID: 19571472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of short-term treatment with pivalic acid containing antibiotics on serum carnitine concentration--a risk irrespective of age.
    Abrahamsson K; Holme E; Jodal U; Lindstedt S; Nordin I
    Biochem Mol Med; 1995 Jun; 55(1):77-9. PubMed ID: 7551831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and pharmacokinetics of CS-834, a new oral carbapenem antibiotic, in healthy volunteers.
    Umemura K; Ikeda Y; Kondo K; Nakashima M; Naganuma H; Hisaoka M; Nishino H; Tajima M
    Antimicrob Agents Chemother; 1997 Dec; 41(12):2664-9. PubMed ID: 9420036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma carnitine and renal-carnitine clearance during pregnancy.
    Cederblad G; Fåhraeus L; Lindgren K
    Am J Clin Nutr; 1986 Sep; 44(3):379-83. PubMed ID: 3751959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Na+/L-carnitine transporter (OCTN2) in renal handling of pivaloylcarnitine and valproylcarnitine formed during pivalic acid-containing prodrugs and valproic acid treatment.
    Ohnishi S; Okamura N; Sakamoto S; Hasegawa H; Norikura R; Kanaoka E; Takahashi K; Horie K; Sakamoto K; Baba T
    Drug Metab Pharmacokinet; 2008; 23(4):293-303. PubMed ID: 18762717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carnitine disposition before and during valproate therapy in patients with epilepsy.
    Riva R; Albani F; Gobbi G; Santucci M; Baruzzi A
    Epilepsia; 1993; 34(1):184-7. PubMed ID: 8422857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.